PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity

By afschroeder • September 6, 2025

Yang S, Santelli E, Gonzalez CG, Johnson WT, Choi IV, Zhuang C, Ro M, Rossitto LM, Yu IS, Lin SW, Zhan Y, Chen Q, Yoshihara JD, Wallace DJ, Jefferies CA, Yamashita M, Gonzalez DJ, Ainsworth RI, Shah NJ, Stanford SM, Bottini N. PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity. Sci Adv. 2025 Sep 5;11(36):eadw2568. doi: 10.1126/sciadv.adw2568. Epub 2025 Sep 5. PMID: 40911684; PMCID: PMC12412669.

Tags: Cedars Sinai DoM, Publications, Rheumatology

Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis

Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ, Lo MC, Budoff M, Shaw L, Shufelt C, Wei J, Gulati M, Merz[...]

Public Health

Tan ZS, Qureshi N, Sicotte N, Escovedo C, Hirsch A, Afrashteh A, Miles PB, Roberts P. Public Health. Alzheimers Dement. 2025 Dec;21 Suppl 6(Suppl 6):e101651.[...]

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions

Patil T, Lin JJ, Cheema PK, Carrizosa DR, Burkard ME, Elamin YY, Desai J, Patel JD, Nagasaka M, Reckamp KL, Waqar SN, Bauman JR, Schram[...]